ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Panacea Acquisition Corp

Panacea Acquisition Corp (NUVB)

2,38
-0,03
(-1,24%)
Fermé 09 Février 10:00PM
2,40
0,02
(0,84%)
Après les heures de négociation: 11:22PM

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

Dernier
2,40
Prix Achat
-
Prix Vente
-
Volume échangé
2 396 724
2,29 Fourchette du Jour 2,42
1,57 Plage de 52 semaines 4,1598
Cap du marché
Clôture Veille
2,41
Ouverture
2,41
Dernière Transaction
100
@
2.4
(formt)
Dernière heure de transaction
Volume financier
US$ 5 619 126
VWAP
2,3445
Volume moyen (3 m)
2 542 442
Actions en circulation
336 566 525
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-10,57
Bénéfice par action (BPA)
-0,23
Chiffre d'affairess
-
Bénéfice net
-75,8M

À propos de Panacea Acquisition Corp

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's proprietary portfolio includes around six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of t... Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's proprietary portfolio includes around six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
Siège social
Wilmington, Delaware, USA
Fondé
-
Panacea Acquisition Corp est coté dans le secteur Pharmaceutical Preparations de la New York Stock Exchange avec le ticker NUVB. Le dernier cours de clôture d'Panacea Acquisition était de US$2,41. Au cours de la dernière année, les actions de Panacea Acquisition ont été négociées dans une fourchette de prix de US$ 1,57 à US$ 4,1598.

Panacea Acquisition compte actuellement 336 566 525 actions en circulation. La capitalisation boursière d'Panacea Acquisition est de US$811,13 million. Panacea Acquisition a un ratio cours/bénéfice (ratio PE) de -10.57.

NUVB Dernières nouvelles

Nuvation Bio Announces Expanded Access Program in the U.S. for Taletrectinib in Advanced ROS1-positive Non-Small Cell Lung Cancer

Nuvation Bio Inc. (NYSE: NUVB), a global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced it has initiated an Expanded Access Program (EAP) for...

Nuvation Bio to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Nuvation Bio Inc. (NYSE: NUVB), a global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced that David Hung, M.D., Founder, President, and Chief...

Nuvation Bio Receives Approval from China’s National Medical Products Administration for Taletrectinib for Patients with Advanced ROS1-positive Non-Small Cell Lung Cancer

Taletrectinib will be marketed in China by Innovent Biologics Approval is based on the pivotal Phase 2 TRUST-I study, demonstrating taletrectinib's durable responses and prolonged...

U.S. Food and Drug Administration Accepts for Priority Review Nuvation Bio’s New Drug Application for Taletrectinib for the Treatment of Advanced ROS1-positive Non-Small Cell Lung Cancer

New Drug Application (NDA) is based on pooled data from the pivotal Phase 2 TRUST-I and TRUST-II studies of taletrectinib that demonstrated durable responses and prolonged progression-free...

Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration

Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration PR Newswire SAN FRANCISCO and SUZHOU, China, Dec. 20...

Nuvation Bio to Present at the 7th Annual Evercore ISI HealthCONx Conference

Nuvation Bio Inc. (NYSE: NUVB), a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced that David Hung, M.D., Founder...

Nuvation Bio to Present at the Jefferies London Healthcare Conference

Nuvation Bio Inc. (NYSE: NUVB), a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced that David Hung, M.D., Founder...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.010.4184100418412.392.49072.22519444372.35266348CS
4-0.49-16.9550173012.892.992.22524437192.5302566CS
12-0.44-15.49295774652.843.4552.22525424422.7071486CS
26-0.64-21.05263157893.043.455220325812.6875494CS
520.7646.34146341461.644.15981.5717802812.82751462CS
156-3.39-58.54922279795.796.050.9511400672.66248366CS
260-7.6-761015.230.9510762844.15815969CS

NUVB - Frequently Asked Questions (FAQ)

What is the current Panacea Acquisition share price?
The current share price of Panacea Acquisition is US$ 2,40
How many Panacea Acquisition shares are in issue?
Panacea Acquisition has 336 566 525 shares in issue
What is the market cap of Panacea Acquisition?
The market capitalisation of Panacea Acquisition is USD 811,13M
What is the 1 year trading range for Panacea Acquisition share price?
Panacea Acquisition has traded in the range of US$ 1,57 to US$ 4,1598 during the past year
What is the PE ratio of Panacea Acquisition?
The price to earnings ratio of Panacea Acquisition is -10,57
What is the reporting currency for Panacea Acquisition?
Panacea Acquisition reports financial results in USD
What is the latest annual profit for Panacea Acquisition?
The latest annual profit of Panacea Acquisition is USD -75,8M
What is the registered address of Panacea Acquisition?
The registered address for Panacea Acquisition is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Panacea Acquisition website address?
The website address for Panacea Acquisition is ecor1cap.com
Which industry sector does Panacea Acquisition operate in?
Panacea Acquisition operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
DOCSDoximity Inc
US$ 79,21
(35,96%)
10,26M
BBAIBigBear ai Holdings Inc
US$ 8,595
(26,96%)
231,27M
SWISolarWinds Corporation
US$ 18,331
(21,96%)
10,07M
ESEESCO Technologies Inc
US$ 158,57
(19,75%)
331,73k
PINSPinterest Inc
US$ 40,00
(19,08%)
51,46M
BILLBILL Holdings Inc
US$ 62,13
(-35,52%)
28,46M
ELFe l f Beauty Inc
US$ 71,13
(-19,62%)
23,55M
GHMGraham Corp
US$ 39,69
(-16,05%)
622,53k
MUXMcEwen Mining Inc
US$ 7,37
(-14,80%)
10,33M
SKXSkechers USA
US$ 66,03
(-12,68%)
10,54M
BBAIBigBear ai Holdings Inc
US$ 8,595
(26,96%)
231,27M
FFord Motor Company
US$ 9,24
(-0,22%)
140,89M
UBERUber Technologies Inc
US$ 74,60
(6,59%)
81,99M
BBDBanco Bradesco SA
US$ 2,105
(-5,61%)
79,66M
QBTSD Wave Quantum Inc
US$ 5,8097
(-3,01%)
59,28M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock